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Introduction
Gallbladder cancer (GBC) is the most common biliary tract cancer and the fifth most common gastrointestinal malignancy worldwide (1) . The prognosis of GBC remains extremely poor despite recent advances in GBC treatment, with a median survival time of 9.2 months for suspected carcinomas and 26.5 months for incidental GBC (2, 3) . Although great efforts have been put into clarifying the pathophysiological mechanisms contributing to the progression of GBC, much of it remains unknown (4, 5) . Thus, it is vital to reveal the molecular mechanisms of gallbladder carcinogenesis to facilitate development of novel cancer biomarkers and appropriate therapeutic strategies.
Long non-coding RNAs (lncRNAs), a subgroup of non-cdoing RNAs (ncRNAs), are longer than 200 nucleotides in length and with little protein-coding potential (6, 7) . Author Manuscript Published OnlineFirst on July 22, 2016; DOI: 10.1158/0008-5472. controlling multiple levels of the gene expression, including carcinogenesis (8) (9) (10) (11) . A growing volume of literature has demonstrated that lncRNAs expression profiling may facilitate the diagnosis of human cancers (12) (13) (14) . They have the potential to serve as prognostic indicators and therapeutic targets. Although over 95000 human lncRNAs have been annotated (15) , only a few of them have been functionally characterized. In our previous studies, we have identified several dysregulated lncRNAs in GBC (16) (17) (18) ). Yet, there have been no systematic profiling studies of lncRNAs in gallbladder cancer up until now.
Although emerging evidence has shown the paramount role of lncRNAs in tumor development, only a small portion of them, such as HOX transcript antisense RNA (HOTAIR) and metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) have been well characterized in various carcinomas (6) . Unlike the well-established molecular mechanism of microRNAs (miRs) action (19) , which is based on seed sequence base-pairing, the action mode of lncRNAs remains to be explored. Studies revealed that lncRNAs may interact with DNA, RNA or protein and regulate a large number of genes with different mechanisms, thereby impacting a variety of cellular pathways (9) (10) (11) (12) (13) (14) (15) . Thus, the molecular mechanisms of lncRNAs action can be diversified and require intensive investigations.
In the present study, through transcriptome microarray analysis, we found a number of lncRNAs dysregulated in GBC compared with paired nontumoral tissues. Among Author Manuscript Published OnlineFirst on July 22, 2016; DOI: 10.1158/0008-5472. the downregulated lncRNAs, we further characterized the clinicopathologic relevance of a novel lncRNA GCASPC (gallbladder cancer associated suppressor of pyruvate carboxylase lncRNA) in GBC progression. GCASPC interacted with pyruvate carboxylase protein in GBC cells, and the anti-proliferative functions of GCASPC can be neutralized by pyruvate carboxylase. We provided in vitro and in vivo data to demonstrate that GCASPC, which is a target of miR-17-3p, suppressed cell proliferation in GBC by destabilization of pyruvate carboxylase protein.
Materials and Methods

Microarray and computational analysis
Briefly, samples (five GBC tissues and five corresponding nontumor tissues; Supplemental 
Patients and Clinical Samples
The human specimens in this study were sanctioned by the local ethics committee at the Shanghai Jiao-Tong University School of Medicine, Xinhua Hospital (Shanghai, China). Two independent cohorts involving 131 GBC patients were enrolled in this study. Forty-two fresh GBC tissue pairs were collected from patients at Xinhua Patients' clinical information is listed in Supplementary Table 2 and Supplementary   Table 3 . The data do not contain any information that could identify patients. None of the patients received preoperative treatment, including chemotherapy or radiotherapy.
The nontumorous samples were taken at a distance of at least 5 cm from the tumor, and all tissues were examined histologically.
Cell culture
Four human GBC cell lines (GBC-SD, SGC-996，NOZ and OCUG-1) were used in this study. GBC-SD, SGC-996, NOZ, OCUG-1 and the non-tumorigenic human intrahepatic biliary epithelial cell line H69 were purchased from the Health Science Research Resources Bank (Osaka, Japan) on July 2013 where they were characterized by Mycoplasma detection, DNA-fingerprinting, isozyme detection, and cell vitality detection. The last cell characterization with the above methods was performed on March, 2015. These cell lines were immediately expanded and frozen such that they could be restarted every 3 to 4 months from a frozen vial of the same batch of cells.
Cells were cultured at 37°C in an atmosphere of 5% CO 2 in Dulbecco's modified Eagle's medium (Gibco BRL) supplemented with 10% fetal bovine serum, penicillin, and streptomycin (Thermo Scientific). The passage numbers for GBC-SD, SGC-996, NOZ, OCUG-1 and H69 were 16, 11, 9, 23 and 10, respectively. All cell lines have been passaged for fewer than 6 months in our laboratory after resuscitation.
5'and 3'rapid amplification of cDNA ends (RACE) analysis, Subcellular
fractionation analysis and assessment of protein-coding potential RACE analysis and subcellular fractionation analysis were performed as described previously (18) . We determined the protein-coding potential of transcript using an in vitro translation assay and a combination of protein-coding potential assessment software.
Plasmid construction, lentiviral construction, and cell transfections
Detailed descriptions of plasmid construction, lentiviral vector construction, and cell transfections can be found in the Supplementary Materials and Methods section. 
RNA preparation, qRT-PCR and Western blot analysis
RNA preparation, qRT-PCR and Western blot analysis were performed as described previously [18] .
Measurement of Cell proliferation, cell cycle
Cell proliferation was determined with Cell Counting Kit-8 (CCK-8). Cell cycle was determined with flow cytometric analysis. The experiments were performed as described by Li et al (12) .
In vivo tumor growth assay and immunohistochemical analysis
Statistical analysis
All statistical analyses were performed using SPSS version 17.0 software (Chicago, IL, USA). All data are presented as the mean ± standard deviation. Unless otherwise noted, the differences between two groups were analyzed using Student's t-test. The Kaplan-Meier method was used to calculate survival, and significance was determined by log-rank test. Multivariate logistic regression was performed to identify the independent factors related to GBC prognosis. The relationship between GCASPC expression levels and clinical parameters was assessed with the nonparametric Mann-Whitney-Wilcoxon test. Risk score analysis was performed to investigate the effectiveness of the GCASPC for prediction. Correlations between GCASPC and miR-17-3p were analyzed by Spearman rank correlation. P-values were two-sided and a value of <0.05 was considered to be statistically significant. One asterisk and two asterisks indicate p < 0.05 and p < 0.01, respectively.
Results
LncRNAs Expression Profile in GBC
To identify transcripts that potentially drive gallbladder tumorigenesis, lncRNAs and mRNAs expression profiles were determined by microarray analysis. A hierarchical 
Cellular characterization of GCASPC
In the present study, we focused on the lncRNAs that are significantly downregulated in GBC tissues. We identified a modestly conserved GCASPC (lnc-SOD2-1:1, LNCipedia annotation; NONHSAT115853, NONCODE v4; RP1-56L9.7-001, GENCODE v13) on human chromosome 6; 160060339-160061133 as one of the top ranked candidates with a significant p value (p=0.003, p<0.05). We noted that GCASPC was located within the intron of insulin-like growth factor 2 receptor (IGF2R, Supplemental Figure 3A ). To explore the potential relationship of the GCASPC and IGF2R transcripts, we first examined the expression levels in 27 GBC tissues (cohort 1). The results showed that no correlation (r 2 =0.031; p=0.377) existed between the transcript levels of GCASPC and IGF2R (Supplemental Figure 3B ). against GCASPC (Supplemental Figure 3D) . GCASPC is polyadenylated (Supplemental Figure 3E) . GCASPC was composed of two exons and spanned nearly 740 base pairs (bp), identifying it as a modestly conserved locus (Supplemental Figure 3F ). The sequence of full-length GCASPC is presented in Supplemental Figure   4 . We verified that GCASPC was indeed a non-coding RNA with an in vitro translation assay (Supplemental Figure 5A GBC is likely to be regulated by histone acetylation.
LnRNA-GCASPC is downregulated in GBC tissues and correlated with GBC progression
To further investigate the role of GCASPC in GBC, we examined 42 paired GBC/nontumor tissue specimens (Supporting Table 2 , cohort 1). The transcript levels of GCASPC was significantly lower in GBC tissues, after normalizing to U6 expression (p<0.001, Figure 1B) . Furthermore, receiver operating characteristic (ROC) curves were determined to evaluate the sensitivity and specificity of GCASPC expression in predicting gallbladder cancer tissues from normal tissues. Notably, GCASPC displayed considerable predictive significance, with an area under curve (AUC) of 0.697 (95% CI (confidence interval) = 0.584-0.810, p=0.002; Figure 1C ).
According to the median ratio of relative GCASPC expression in tumor tissues, the GBC patients were classified into two groups: High-GCASPC group: GCASPC expression ratio≥median ratio; and Low-GCASPC group: GCASPC expression ratio ≤median ratio. To determine whether GCASPC expression level in GBC was associated with specific clinicopathological characteristics, we measured GCASPC expression levels in tumor tissues from another 89 GBC patients independent from 42 GBC patients of cohort 1 (Supplemental Table 3 Table 4 ). Furthermore, Kaplan-Meier and log-rank test analyses suggested a correlation between low tumoral GCASPC expression and reduced overall survival (OS) and disease-free survival (DFS) rates (p < 0.001 for both OS and DFS, Figure 1E,F) . In addition, multivariate analysis showed that GCASPC expression (95% CI: 1.421-5.034; p= 0.006) and local invasion status (95% CI: 1.342-5.579; p= 0.005) were independent factors that affected the OS of GBC patients after radical GBC resection (supplemental Table 5 ).
LnRNA-GCASPC suppresses GBC cell proliferation
To evaluate the biological effects of GCASPC on development of GBC, we performed 
We sought to explore the molecular mechanisms by which GCASPC exerts its effects on GBC cell proliferation. As lncRNAs have been reported to exert cis-regulatory effects on nearby genes (20), we examined whether manipulation of GCASPC expression levels would affect the mRNA levels of its in cis genes. As demonstrated in Supplemental Figure 9A , no statistical changes in the transcript levels of neighbouring genes were observed in SGC-996 cells with GCASPC overexpression, as represented by SOD2, MAS1, loc729603, AIRN and SLC22A1. It suggests GCASPC may act in trans. Recent studies have suggested that lncRNAs participate in molecular regulation pathways through interacting with proteins (9, 12) . Thus, we hypothesized that GCASPC might function through a similar mechanism. To test this hypothesis, we performed RNA-pulldown assays to identify proteins associated with GCASPC RNA in NOZ cells as previously described (9) . RNA-associated proteins were analyzed by SDS/PAGE and silver staining ( Figure 3A) . Three distinct bands specific to GCASPC were excised and subjected to mass spectrometry (Supplemental Table 6 ). PC was detected by western blotting from three independent RNA pull-down assays in cell extracts from SGC-996 and NOZ cells ( Figure 3B ). The specificity of this interaction was further verified with RIP ( Figure 3C) . Notably, deletion-mapping analyses identified that 3'-end segment (472-741 nt) of GCASPC is required for the association with PC ( Figure 3D ). RNA folding analyses (21) of this 3' region indicated a stable stem-loop structure (Supplemental Figure 9B) , which might provide the necessary spatial conformation for the interaction. In addition, we found that PC was significantly upregulated in GBC tissues compared to adjacent nontumor 
tissues (Supplemental Figure 9C ). As mentioned above (Supplemental Figure 5D) , GCASPC is mainly located in the cytoplasm of GBC cells. We further detected the subcellular fractionation of GCASPC because PC is a mitochondria protein. We isolated pure mitochondria fractionation via standard cellular fractionation methods and found that GCASPC was mainly located in the mitochondria fraction ( Figure 3E ).
Then we analyzed the interaction between GCASPC and PC in the cytoplasmic (without mitochondria) and mitochondria fraction. The RIP analysis demonstrated that the interaction between GCASPC and PC specifically takes place in the mitochondria fraction ( Figure 3F ).
Next, we sought to characterize the effects of GCASPC on PC. We detected a significant upregulation of the PC protein and PC activity upon GCASPC knockdown in both GBC-SD ( Figure 4A ) and OCUG-1 cells (Supplemental Figure 10A) , and a downregulation of the PC protein and PC activity in GCASPC-overexpressing SGC-996 ( Figure 4A ) and NOZ cells (Supplemental Figure 10B ), but we did not observe a significant change in PC mRNA levels (Supplemental Figure 10C,D) . As Based on this finding, we hypothesize that GCASPC binds to PC and affects its biological activity at the translational or post-translational level. To identify these hypotheses, we firstly observed the expression of PC proteins in GBC cells incubated with the protein synthesis inhibitor cycloheximide (CHX). As shown in Figure 4B , CHX decreased the expression of PC proteins by inhibiting protein synthesis.
However, knockdown GCASPC still induced the upregulation of PC protein levels under the treatment of CHX ( Figure 4B ). These results suggest that GCASPC might promote the PC protein degradation. We used the proteasome inhibitor MG-132 to further clarify the possible mechanism. Firstly, ectopic expression of GCASPC downregulated the protein levels of PC ( Figure 4A ), suggesting that GCASPC Figure 4C , MG-132 upregulated the protein levels of PC, suggesting that the inhibition of ubiquitination-proteasome pathway might ameliorate the degradation of PC. The last but not the least, MG-132 abolished the reduction of PC protein levels in GCASPC-overexpressing SGC-996 ( Figure 4C) and NOZ cells (Supplemental Figure 11A) . We further examined whether GCASPC affects PC protein stability by performing an ubiquitination assay and found that the PC ubiquitination level was significantly higher in cells that overexpressed GCASPC relative to control cells (Supplemental Figure 11B) . These data indicate that GCASPC downregulates PC protein abundance via the ubiquitination-proteasome pathway. Collectively, these data suggest that GCASPC suppressed tumorigenesis by negatively regulates PC-dependent cell proliferation.
destabilized PC protein. As illustrated in
GCASPC is direct target of miR-17-3p
A competitive RNA (ceRNA) hypothesis has been proposed and recent studies have suggested that interaction between lncRNAs and microRNAs (miRNAs) (10, 11, 16) , imposing an additional level of posttranscriptional regulation. We performed a search for miRNAs that have complementary base pairing with GCASPC, using online software program miRDB (http://mirdb.org) (22) . The search results demonstrated that 30 miRNAs formed complementary base pairing with GCASPC (Supplementary Table 5 ). As miR-17-3p achieved the highest score according to miRDB and formed no complementary base pairing with PC mRNA according to Targetscan, we selected it for further studies. What's more, other miRNAs on the list shared no common interaction site with miR-17-3p (Supplementary Table 7 ). According to the prediction results, there was one putative miR-17-3p binding site in exon 2 of GCASPC ( Figure   5A ). To confirm the direct binding between GCASPC and miR-17-3p, luciferase reporter constructs were generated. We observed that miR-17-3p mimics reduced the luciferase activities of wild-type (WT) GCASPC reporter vector, but not a mutant GCASPC, indicating that miR-17-3p binds to GCASPC in a sequence-specific manner.
We further clarified the regulatory relationship between GCASPC and miR-17-3p.
Overexpression of miR-17-3p significantly suppressed the expression of GCASPC in Figure 12A) . However, there was no obvious difference in miR-17-3p level after overexpression or knockdown of GCASPC ( Figure 5B ; Supplemental Figure 12B ). It suggests that GCASPC is targeted by miR-17-3p. To distinguish between a transcriptional and a posttranscriptional mechanism, we treated GBC-SD cells with alpha-amanitin, which blocked RNA Polymerase II transcription. This experiment revealed that overexpression of miR-17-3p decreased the GCASPC half-life ( Figure   5C ). The microRNAs are known to bind their targets and cause translational repression and/or RNA degradation in an Ago2-dependent manner. We performed RNA pull-down experiments by using GCASPC probe and then examined Ago2 and miR-17-3p simultaneously as described previously (18) to determine whether GCASPC and miR-17-3p are in the same RISC complex. The in vitro RNA pull-down experiment was performed to confirm the direct physical association between GCASPC and Ago2. As a result, we detected Ago2 (Supplemental Figure 12C) . Furthermore, we detected miR-17-3p in the same pellet, supporting that miR-17-3p is bona fide GCASPC -targeting miRNA (Supplemental Figure 12D) . Furthermore, miR-17-3p knockdown suppressed the proliferation and expression levels of PC in GCASPC-knockdown GBC-SD cells ( Figure 5D,E) . A statistically significant inverse correlation was observed between GCASPC and miR-17-3p transcript levels in 42 GBC specimens (r=-0.498, p=0.002, Figure 5F ). In general, these data suggest that miR-17-3p directly binds to GCASPC and negatively regulates GCASPC-mediated 
Discussion
The molecular classification of GBC have identified a number of protein-coding genes as valuable biomarkers and prognostic indicators (4, 5, 23) . However, a poor overlap exists between these biomarkers of GBC. Thus, it might be a better resolution to establish more-accurate prognostic gene signatures by using a combination of different types of transcripts (24) . A growing volume of literature has demonstrated that noncoding RNAs, predominantly miRNAs, could serve as potential biomarkers of GBC (3, 25) . Given the fact that lncRNAs are more abundantly expressed in mammalian cells, it is plausible to speculate that lncRNAs, once regarded as 'transcriptional noise', may be potential prognostic indicators in GBC. Although thousands of lncRNAs have been annotated (15) , functional interpretation has just started.
In the present study, we revealed signatures of a small number of lncRNAs that are aberrantly expressed in human GBC, compared to nontumor tissues. We identified a new lncRNA transcript (GCASPC), which was significantly downregulated in GBC tissues from two cohorts of patients. We determined that the low expression level of 
was an independent risk factor for OS after surgery. These data suggest that GCASPC can be a potential prognostic indicator for GBC.
By applying loss-of and gain-of-function approaches, we identified that GCASPC play a role in cell proliferation and cell cycle progression. Although it has been suggested that some lncRNAs act in cis (neighboring genes) through transcriptional interference, the majority of lncRNAs primarily function in trans by targeting multiple chromatin regulatory proteins to distant genes (26) . Here, we identified that GCASPC had no effect on the expression level of neighboring genes, suggesting that GCASPC functions in trans. The GCASPC transcript was found to associate with pyruvate carboxylase (PC) to promote PC protein degradation. However, the underlying mechanisms of GCASPC regulates the ubiquitination and/or ubiquitination associated enzymes require further investigation. PC, an enzyme that converts pyruvate to oxaloacetate, has recently been demonstrated to play an important role in cancer cell metabolism and proliferation (27, 28) . We also found that the GCASPC abrogated PC-mediated GBC cell proliferation, indicating that GCASPC function in a PC-dependent manner. Enhanced glycolysis under aerobic conditions (the Warburg effect) has been a hallmark of cancer for many decades (29) . However, accelerated glycolysis alone is insufficient to meet the total metabolic demands of proliferating cancer cells. The Krebs cycle is also a source of energy via the oxidation of pyruvate, fatty acids and amino acids such as glutamine (27) . Continued functioning of the Krebs cycle requires the replenishment of intermediates that are diverted for anabolic CAN-15-3047 uses or glutathione synthesis, which was accomplished via 2 major pathways: carboxylation of pyruvate to oxaloacetate via ATP-dependent pyruvate carboxylase (PC) (27) and glutaminolysis (30) . We presume that the inhibition of gallbladder cancer cell proliferation by PC suppression with GCASPC upregulation is accompanied by a decrease in anaplerotic input into the Krebs cycle, which has been verified in NSCLC cells with PC suppression (27) . However, whether it is true in this case requires further investigation.
A growing number of reports suggests the existence of a widespread interaction network involving ceRNAs, where ncRNAs could regulate modulatory RNA by binding and titrating them off their binding sites on protein coding messengers (31, 32) .
Inspired by the discoveries of the interaction between lncRNAs and miRs (33, 34) , we sought to identify the role of miRNAs in the regulation of lncRNAs. Luciferase assays indicated that miR-17-3p directly binds to GCASPC. MiR-17-3p overexpression silenced GCASPC in GBC cells. Furthermore, GCASPC transcript level was inversely correlated with miR-17-3p mRNA level in GBC tissues. However, the alignment between the GCASPC and miR-17-3p is not very specific, as 30 miRNAs were predicted to form complementary base pairing with GCASPC. What's more, miR-17-3p may also act independently of miR-17-3p, as it shares homology with a number of protein-coding genes such as TIMP3 (35) and MDM2 (36) . In addition to miRNAs, lncRNAs could also be regulated by typical transcriptional factor [37, 38] [41]. Our data revealed that GCASPC was upregulated by the histone deacetylase inhibitor trichostatin A (TSA), suggesting that GCASPC expression in GBC is likely to be regulated by histone acetylation. The precise molecular mechanism of the downregulation of GCASPC in GBC calls for further research.
In summary, we showed the detailed mechanistic insight of miR-17-3p-GCASPCpyruvate carboxylase axis in gallbladder cancer. This finding suggests that GCASPC may be the important target for tumor therapy. Differences among variable were assessed by chi-square test.*, the values had statistical significant differences.
